Placebo effects and neuromodulation for depression: a meta-analysis and evaluation of shared mechanisms. Ted Jack Kaptchuk Burke MJ, Romanella SM, Mencarelli L, Greben R, Fox MD, Kaptchuk TJ, Pascual-Leone A, Santarnecchi E. Tue, 03/01/2022 - 12:00 Mol Psychiatry http://www.ncbi.nlm.nih.gov/pubmed/34903861
Author Correction: Distinct thalamocortical network dynamics are associated with the pathophysiology of chronic low back pain. Ted Jack Kaptchuk Tu Y, Fu Z, Mao C, Falahpour M, Gollub RL, Park J, Wilson G, Napadow V, Gerber J, Chan ST, Edwards RR, Kaptchuk TJ, Liu T, Calhoun V, Rosen B, Kong J. Tue, 08/25/2020 - 12:00 Nat Commun http://www.ncbi.nlm.nih.gov/pubmed/32843661
Improved health outcomes in integrative medicine visits may reflect differences in physician and patient behaviors compared to standard medical visits. Ted Jack Kaptchuk Dossett ML, Hall JA, Kaptchuk TJ, Yeh GY, Dossett ML, Hall JA, Kaptchuk TJ, Yeh GY, Dossett ML, Hall JA, Kaptchuk TJ, Yeh GY. Mon, 02/01/2021 - 12:00 Patient Educ Couns http://www.ncbi.nlm.nih.gov/pubmed/32811749
Peppermint Oil Treatment for Irritable Bowel Syndrome: A Randomized Placebo-Controlled Trial. Ted Jack Kaptchuk Nee J, Ballou S, Kelley JM, Kaptchuk TJ, Hirsch W, Katon J, Cheng V, Rangan V, Lembo A, Iturrino J. Mon, 11/01/2021 - 12:00 Am J Gastroenterol http://www.ncbi.nlm.nih.gov/pubmed/34319275
Patients' experiences treated with open-label placebo versus double-blind placebo: a mixed methods qualitative study. Ted Jack Kaptchuk Haas JW, Ongaro G, Jacobson E, Conboy LA, Nee J, Iturrino J, Rangan V, Lembo A, Kaptchuk TJ, Ballou S. Fri, 02/04/2022 - 12:00 BMC Psychol http://www.ncbi.nlm.nih.gov/pubmed/35120572
Are They Side Effects? Extraintestinal Symptoms Reported During Clinical Trials of Irritable Bowel Syndrome May Be More Severe at Baseline. Ted Jack Kaptchuk Ballou S, Hassan R, Nee J, Iturrino J, Rangan V, Cheng V, Conboy L, Kirsch I, Lembo A, Kaptchuk TJ, Kelley J. Thu, 12/01/2022 - 12:00 Clin Gastroenterol Hepatol http://www.ncbi.nlm.nih.gov/pubmed/35339669
Effect of Open-label Placebo on Children and Adolescents With Functional Abdominal Pain or Irritable Bowel Syndrome: A Randomized Clinical Trial. Ted Jack Kaptchuk Nurko S, Saps M, Kossowsky J, Zion SR, Di Lorenzo C, Vaz K, Hawthorne K, Wu R, Ciciora S, Rosen JM, Kaptchuk TJ, Kelley JM. Fri, 04/01/2022 - 12:00 JAMA Pediatr http://www.ncbi.nlm.nih.gov/pubmed/35099543
Placebos in pediatrics: A cross-sectional survey investigating physicians' perspectives. Ted Jack Kaptchuk Faria V, Talbert C, Goturi N, Borsook D, Lebel A, Kaptchuk TJ, Kirsch I, Kelley JM, Moulton EA. Fri, 09/01/2023 - 12:00 J Psychosom Res http://www.ncbi.nlm.nih.gov/pubmed/37354748
Open-label placebo for chronic low back pain: a 5-year follow-up. Ted Jack Kaptchuk Carvalho C, Pais M, Cunha L, Rebouta P, Kaptchuk TJ, Kirsch I. Sat, 05/01/2021 - 12:00 Pain http://www.ncbi.nlm.nih.gov/pubmed/33259459
Conditioned open-label placebo for opioid reduction after spine surgery: a randomized controlled trial. Ted Jack Kaptchuk Flowers KM, Patton ME, Hruschak VJ, Fields KG, Schwartz E, Zeballos J, Kang JD, Edwards RR, Kaptchuk TJ, Schreiber KL. Tue, 06/01/2021 - 12:00 Pain http://www.ncbi.nlm.nih.gov/pubmed/33449503
